Original language | English (US) |
---|---|
Pages (from-to) | E592-E594 |
Journal | Critical care medicine |
Volume | 50 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2022 |
Funding
Dr. Garibaldi received funding from Janssen Research and Development, Gilead Life Sciences, and Atea Pharmaceuticals. The remaining authors have disclosed that they do not have any potential conflicts of interest.
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine